Immuneering (IMRX) Non-cash Items (2021 - 2022)
Immuneering (IMRX) recorded quarterly Non-cash Items of $2.7 million in Q4 2022, down 89.51% quarter-over-quarter from $25.9 million in Q3 2022, and down 90.17% on a YoY basis from $27.6 million in Q4 2021.
Immuneering (IMRX) Non-cash Items (2021 - 2022) Analysis & Trends
Immuneering's Non-cash Items history runs 2 years deep, the most recent figure standing at $2.7 million for Q4 2022.
- In Q4 2022, Non-cash Items fell 90.17% year-over-year to $2.7 million; the TTM figure through Dec 2022 stood at $2.7 million (down 90.17% YoY), while the FY2022 annual figure was $2.7 million, down 90.17% from the prior year.
- Non-cash Items was $2.7 million for Q4 2022 at Immuneering, down from $25.9 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $56.3 million in Q3 2021 to a low of $2.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.72 Mn |
| Dec 31, 2022 | 2.72 Mn |
| Sep 30, 2022 | 25.89 Mn |
| Sep 30, 2022 | 25.89 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Mar 31, 2022 | 5.29 Mn |
| Mar 31, 2022 | 5.29 Mn |
| Dec 31, 2021 | 27.62 Mn |
| Dec 31, 2021 | 27.62 Mn |
| Sep 30, 2021 | 56.34 Mn |
| Sep 30, 2021 | 56.34 Mn |
| Jun 30, 2021 | 11.55 Mn |
| Jun 30, 2021 | 11.55 Mn |